Replies to post #1348 on Molecular Templates Inc (fka MTEMQ)

[vip1999]

Just made a suckers bet for Mar 7.50 call for .10@. If this thing blow $7.60 by Thursday, I will make some money!LOL.

[No-dough-go]

What about this Ron?

In the U.S., Threshold will be responsible for the development of TH-302 in the soft tissue sarcoma indication, while both companies will jointly develop the drug in all other cancer indications. Merck KGaA will pay 70% of worldwide development costs for TH-302.

[bleu22]

Power hour!